Table 2 Cost-effectiveness of therapy as assessed by 38 prescribers during cycle A and cycle B
Cost-effective | Number and percentage in cycle A | Number and percentage in cycle B |
|---|---|---|
Yes | 30 (78.95%) | 31 (81.58%) |
No | 5 (13.16%) | 5 (13.16%) |
Sometimes | 3 (7.89%) | 2 (5.26%) |